value of mrd in patients with npm1-mutated aml
Published 3 years ago • 422 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
3:17
mrd status predicts allosct outcomes in npm1-mutated aml: an analysis of aml17 and aml19 studies
-
1:56
mrd negativity in npm1-mutated aml: the influence of co-occurring mutations and flag-ida induction
-
1:06
the importance of mrd monitoring in patients with aml
-
2:59
the prognostic and therapeutic implications of mrd in aml
-
0:48
pre-measure study: assessing the role of ngs mrd in patients with aml receiving sct
-
7:46
updates in aml treatment and research from asco 2023
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
1:56
ngs vs flow cytometry for mrd assessment in npm1-mutated aml
-
1:23
the role of mrd status & the eln 2022 in predicting clinical outcomes of patients with aml
-
4:22
the role of mrd in aml
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
3:27
the role of mrd in aml regulatory decision making
-
1:32
methods to evaluate mrd in aml
-
0:44
the clinical meaning of mrd below the threshold of mcr in aml
-
2:05
mrd in aml clinical practice
-
1:30
the prognostic value of patient-reported outcomes in mds
-
1:26
braf-mutated aml is associated with poor prognosis and myelodysplasia-related mutations
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
2:23
the role of mrd monitoring using mfc for aml: a real-world study
-
1:23
the value of mrd as a marker for disease eradication in aml
-
2:45
mrd in aml: eln recommendations